News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Wyeth CEO to Get $53 Million Under Pfizer Inc. Deal
March 30, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
AP -- Wyeth's chief executive is in line to get a whopping $53 million in severance payments if the drugmaker's pending acquisition by Pfizer Inc. is completed, according to a regulatory filing Friday.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Pfizer
MORE ON THIS TOPIC
Series A
New biotech cAMPfield emerges with $180M to reshape IBD treatment
June 18, 2026
·
2 min read
·
Gabrielle Masson
Manufacturing
Moderna mulls deals to rescue German BioNTech plants from closure: report
June 18, 2026
·
2 min read
·
Nick Paul Taylor
Mergers & acquisitions
Biogen makes up to $1B immuno play with RayThera takeover
June 18, 2026
·
2 min read
·
Tristan Manalac
Deals
Jazz strikes new chord with AbCellera in T cell engager pact that could top $2.4B
June 17, 2026
·
2 min read
·
Gabrielle Masson
